The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Phenylboronic Acid-Installed Polymeric Micelles for Targeting Sialylated Epitopes in Solid Tumors
Abstract
Ligand-mediated targeting of nanocarriers to tumors is an attractive strategy for increasing the efficiency of chemotherapies. Sialylated glycans represent a propitious target as they are broadly overexpressed in tumor cells. Because phenylboronic acid (PBA) can selectively recognize sialic acid (SA), herein, we developed PBA-installed micellar nanocarriers incorporating the parent complex of the anticancer drug oxaliplatin, for targeting sialylated epitopes overexpressed on cancer cells. Following PBA-installation, the micelles showed high affinity for SA, as confirmed by fluorescence spectroscopy even at intratumoral pH conditions, i.e., pH 6.5, improving their cellular recognition and uptake and enhancing their in vitro cytotoxicity against B16F10 murine melanoma cells. In vivo, PBA-installed micelles effectively reduced the growth rate of both orthotopic and lung metastasis models of melanoma, suggesting the potential of PBA-installed nanocarriers for enhanced tumor targeting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Self-citationAccumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429
Self-citationTargeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
Dube, D. H., & Bertozzi, C. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1751 · Cited by 1,598
A detailed examination of boronic acid–diol complexation
Springsteen, G., & Wang, B. (2002) · Tetrahedron · doi:10.1016/s0040-4020(02)00489-1 · Cited by 1,461
Nishiyama, N., & Kataoka, K. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.006 · Cited by 1,052
Self-citationTumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
Hakomori, S. (1996) · PubMed · Cited by 987
Saccharide Sensing with Molecular Receptors Based on Boronic Acid
James, T. D., Sandanayake, K. R. A. S., & Shinkai, S. (1996) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199619101 · Cited by 917
Specific Antigen in Serum of Patients with Colon Carcinoma
Koprowski, H., Herlyn, M., Steplewski, Z., & Sears, H. F. (1981) · Science · doi:10.1126/science.6163212 · Cited by 591
Carbohydrate‐mediated cell adhesion in cancer metastasis and angiogenesis
Kannagi, R., Izawa, M., Koike, T., Miyazaki, K., & Kimura, N. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03219.x · Cited by 572
Preclinical and clinical studies of anticancer agent‐incorporating polymer micelles
Matsumura, Y., & Kataoka, K. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01103.x · Cited by 501
Self-citationPolymeric micelles for nano-scale drug delivery
Miyata, K., Christie, R. J., & Kataoka, K. (2011) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2010.10.009 · Cited by 478
Self-citationLectins: Carbohydrate-specific Reagents and Biological Recognition Molecules
Sharon, N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.x600004200 · Cited by 456
Clinical pharmacokinetics of oxaliplatin: a critical review.
Graham, M. A., Lockwood, G. F., Greenslade, D., Brienza, S., Bayssas, M., & Gamelin, E. (2000) · PubMed · Cited by 455
Bae, Y., Jang, W.-D., Nishiyama, N., Fukushima, S., & Kataoka, K. (2005) · Molecular BioSystems · doi:10.1039/b500266d · Cited by 445
Self-citationPlummer, R., Wilson, R. H., Calvert, H., Boddy, A. V., Griffin, M., Sludden, J., Tilby, M. J., Eatock, M., Pearson, D. G., Ottley, C. J., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.6 · Cited by 390
Self-citationOtsuka, H., Uchimura, E., Koshino, H., Okano, T., & Kataoka, K. (2003) · Journal of the American Chemical Society · doi:10.1021/ja021303r · Cited by 326
Self-citationMartin, G., & Jain, R. K. (1994) · PubMed · Cited by 309
Improving Drug Potency and Efficacy by Nanocarrier-Mediated Subcellular Targeting
Murakami, M., Cabral, H., Matsumoto, Y., Wu, S., Kano, M. R., Yamori, T., Nishiyama, N., & Kataoka, K. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001385 · Cited by 262
Self-citationPolymer therapeutics as nanomedicines: new perspectives
Duncan, R. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.05.507 · Cited by 254
Peptides in cancer nanomedicine: Drug carriers, targeting ligands and protease substrates
Zhang, X.-X., Eden, H. S., & Chen, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.023 · Cited by 243
Osada, K., Christie, R. J., & Kataoka, K. (2009) · Journal of The Royal Society Interface · doi:10.1098/rsif.2008.0547.focus · Cited by 218
Self-citationCabral, H., Nishiyama, N., Okazaki, S., Koyama, H., & Kataoka, K. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.022 · Cited by 201
Self-citationAssessment of Tumor Metastasis by the Direct Determination of Cell‐Membrane Sialic Acid Expression
Matsumoto, A., Cabral, H., Sato, N., Kataoka, K., & Miyahara, Y. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201001220 · Cited by 183
Self-citationAntibody-modified liposomes for cancer chemotherapy
Torchilin, V. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.9.1003 · Cited by 168
Cabral, H., Nishiyama, N., & Kataoka, K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.024 · Cited by 161
Self-citationTomsho, J. W., & Benkovic, S. J. (2012) · The Journal of Organic Chemistry · doi:10.1021/jo202250d · Cited by 109
Chemical Sensing of Polyols with Shapeshifting Boronic Acids As a Self-Contained Sensor Array
Teichert, J. F., Mazunin, D., & Bode, J. W. (2013) · Journal of the American Chemical Society · doi:10.1021/ja404981q · Cited by 102
Crich, S. G., Alberti, D., Szabó, I., Aime, S., & Djanashvili, K. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201207131 · Cited by 94
Kannagi, R., Sakuma, K., Miyazaki, K., Lim, K., Yusa, A., Yin, J., & Izawa, M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01455.x · Cited by 91
Cheng, W., & Allen, T. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903579963 · Cited by 90
Multifunctional nanoassemblies of block copolymers for future cancer therapy
Cabral, H., & Kataoka, K. (2010) · Science and Technology of Advanced Materials · doi:10.1088/1468-6996/11/1/014109 · Cited by 71
Self-citationOba, M., Vachutinsky, Y., Miyata, K., Kano, M. R., Ikeda, S., Nishiyama, N., Itaka, K., Miyazono, K., Koyama, H., & Kataoka, K. (2010) · Molecular Pharmaceutics · doi:10.1021/mp9002317 · Cited by 70
Self-citationTumor‐associated carbohydrate antigens: A possible avenue for cancer prevention
Xu, Y., Sette, A., Sidney, J., Gendler, S. J., & Franco, A. (2005) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2005.01347.x · Cited by 70
Sialic Acid Content of the Erythrocyte and of an Ascites Tumor Cell of the Mouse
Miller, A., Sullivan, J. F., & Katz, J. H. (1963) · The Mouseion at the JAXlibrary (Jackson Laboratory) · Cited by 29
Cited by
Controlled drug delivery vehicles for cancer treatment and their performance
Senapati, S., Mahanta, A. K., Kumar, S., & Maiti, P. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-017-0004-3 · Cited by 2,167
Targeting Strategies for Tissue-Specific Drug Delivery
Zhao, Z., Ukidve, A., Kim, J., & Mitragotri, S. (2020) · Cell · doi:10.1016/j.cell.2020.02.001 · Cited by 1,099
Progress of drug-loaded polymeric micelles into clinical studies
Cabral, H., & Kataoka, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.042 · Cited by 837
Self-citationActive Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems
Yoo, J., Park, C., Yi, G., Lee, D., & Koo, H. (2019) · Cancers · doi:10.3390/cancers11050640 · Cited by 726
Sialic acids sweeten a tumor's life
Büll, C., Stoel, M. A., den Brok, M. H., & Adema, G. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0728 · Cited by 496
Metadata
- Authors
- Deshayes, S., Cabral, H., Ishii, T., Miura, Y., Kobayashi, S., Yamashita, T., Matsumoto, A., Miyahara, Y., Nishiyama, N., & Kataoka, K.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-10-03
- Volume
- 135
- Issue
- 41
- Pages
- 15501-15507
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W2321616752
- Cited by
- 348
- References
- 40
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.